| answer text |
<p>All of the currently authorised COVID-19 vaccines are suitable for use in immunocompromised
individuals, including those with blood cancer. The clinical studies for these vaccines
excluded immunocompromised subjects and therefore no data is currently available regarding
the use of these vaccines when used at the same time as immunosuppressant medicines
or the immune response in those on such medications. However, data is being collected
on use of the vaccines in immunocompromised subjects and the Medicines and Healthcare
products Regulatory Agency will assess this data as soon as it become available. Public
Health England is also monitoring the impact of COVID-19 vaccines on a broad range
of outcomes including symptomatic disease, infection and hospitalisations as set out
in the vaccine surveillance strategy, including protection in different clinical risk
groups.</p>
|
 |
